Showing 20 of 94 recruiting trials for “esophageal-atresia”
Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma
👨⚕️ zhenyu ding, MD, West China Hospital of Sichuan University, ChengDu, China📍 1 site📅 Started Oct 2024View details ↗
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
👨⚕️ Sakti Chakrabarti, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06713993 ↗
Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
Primary Posterior Tracheopexy Prevents Tracheal Collapse
RecruitingNCT06550063 ↗
HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes
👨⚕️ John V Reynolds, MBBCh,MD, Trinity St James Cancer Institute📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06558786 ↗
Registry for Esophageal and Gastroesophageal Junction Cancer
👨⚕️ Daniela Molena, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Aug 2024View details ↗
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
Enrolling by InvitationNCT06475196 ↗
Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Myosteatosis in Oeso-gastric Cancer: Clinical Impacts
👨⚕️ Yannick Deswysen, MD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain📍 1 site📅 Started May 2024View details ↗
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
👨⚕️ Hecheng Li, MD/PHD, Ruijin Hospital Shanghaijiaotong University School of Medicine📍 1 site📅 Started May 2024View details ↗
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
RecruitingNCT07050576 ↗
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
RecruitingNCT06361043 ↗
Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)
👨⚕️ Hossein Hemmatazad, MD, Inselspital Bern, Department of Radio-Oncology📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06402682 ↗
Management of Esophageal Atresia With Right Aortic Arch: Is the Side of Approach Important?
Predicting Esophageal Cancer Borders Using PET-Imaging
Dumping Syndrome and Esophageal Atresia
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
👨⚕️ Pin-I Huang, Ph.D, Taipei Veterans General Hospital, Taiwan📍 1 site📅 Started Feb 2024View details ↗
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →